特一药业集团股份有限公司 2025年度业绩预告

Group 1 - The company expects a positive net profit for the year 2025, with an increase of over 50% compared to the previous year [1] - The performance forecast period is from January 1, 2025, to December 31, 2025 [1] - The company has communicated with the accounting firm regarding the performance forecast, and there are no discrepancies between the company and the accounting firm [1] Group 2 - The change in performance is attributed to the deepening of marketing transformation, advancement of brand strategy, and product recovery [1] - Core product sales have rebounded, and the optimization of marketing channels has contributed to a good recovery in both revenue and overall gross margin [1] - Despite short-term impacts on profits due to brand building investments, the overall operating profit has shown positive improvement, indicating successful marketing reforms and brand development [1]